title: Mycophenolate mofetil for the transplanted kidney?
abstract: Mycophenolate mofetil (CellCept-Roche) is a new immunosuppressant indicated "in combination with cyclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal transplants". Here we review mycophenolate mofetil and assess whether it offers any additional benefits to conventional therapy.
mesh_terms: D000208:Acute Disease; D016527:Drug Costs; D004347:Drug Interactions; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid